Log In
Print this Print this


Also known as: PhosLocalcium acetate

  Manage Alerts
Collapse Summary General Information
Company Fresenius SE & Co. KGaA
DescriptionNon-absorbed phosphate binder
Molecular Target Phosphate
Mechanism of ActionPhosphate binder
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHyperphosphatemia
Indication DetailsTreat hyperphosphatemia; Treat hyperphosphatemia in patients with end-stage renal disease (ESRD); Treat hyperphosphatemia in stage IV pre-dialysis chronic kidney disease (CKD) patients
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today